Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 6, 1999, Pages 1998-2002

  Chiba Falek, Ornit ^a,b,c   Parad, Richard B ^a,b,c   Kerem, Eitan ^a,b,c   Kerem, Batsheva ^a,b,c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALTERNATIVE RNA SPLICING; ARTICLE; CYSTIC FIBROSIS; DISEASE SEVERITY; FETUS; FETUS WASTAGE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

EID: 0033033312     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.6.9808012     Document Type: Article

References (19)

1. 1. Welsh, M. J., L.-C. Tsui, T. F. Boat, and A. L. Beaudet. 1995. Cystic fibrosis. In C.L. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. The Metabolic Basis of Inherited Disease, 7th ed. McGraw-Hill, New York. 3799-3876.
2. 2. Harris, A., G. Chalkley, S. Goodman, and L. Coleman. 1991. Expression of the cystic fibrosis gene in human development. Development 113:305-310.
3. 3. Tizzano, E. F., D. Chitayat, and M. Buchwald. 1993. Cell-specific localization of CFTR RNA shows developmentally regulated expression in human fetal tissues. Hum. Mol. Genet. 2:219-224.
4. 4. Trezise, A. E. O., J. A. Chambers, C. J. Wardle, S. Gould, and A. Harris. 1993. Expression of the cystic fibrosis gene in human fetal tissues. Hum. Mol. Genet. 2:213-218.
5. 5. Kerem, B., and E. Kerem. 1996. The molecular basis for disease variability in cystic fibrosis. Eur. J. Hum. Genet. 4:65-73.
6. 6. Rave-Harel, N., E. Kerem, M. Nissin-Rafinia, I. Madjar, R. Goshen, A. Augarten, A. Rahat, A. Hurwitz, A. Darvasi, and B. Kerem. 1997. The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am. J. Hum. Genet. 60:87-94.
7. 7. Teng, H., M. Jorissen, H. Van Poppel, E. Legius, J. J. Cassiman, and H. Cuppens. 1997. Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells. Hum. Mol. Genet. 6:85-90.
8. 8. Mak, V., K. A. Jarvi, J. Zielenski, P. Durie, and L. C. Tsui. 1997. Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens. Hum. Mol. Genet. 6:2099-2107.
9. 9. Highsmith, W. E., L. H. Burch, Z. Zhou, J. C. Olsen, T. E. Boat, A. Spock, J. D. Gorvoy, L. Quittell, K. J. Friedman, L. M. Silverman, R. C. Boucher, and M. R. Knowles. 1994. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N. Engl. J. Med. 331:974-998.
10. 10. Augarten, A., B. Kerem, Y. Yahav, S. Noiman, Y. Rivlin, A. Tal, H. Blau, L. Ben-Tur, A. Szeinberg, E. Kerem, and E. Gazit. 1993. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849+10 kb C→T mutation. Lancet 342:25-26.
11. 11. Chirgwin, J. M., A. E. Przbyla, R. J. MacDonald, and W. Rutter. 1979. Isolation of biologically active ribonucleic acid from sourees enriched in ribonuclease. Biochemistry 18:5294-5299.
12. 12. Shoshani, T., E. Kerem, A. Szeinberg, A. Augarten, Y. Yahav, D, Cohen, J. Rivlin, A. Tal, and B. Kerem. 1994. Similar levels of mRNA from the W12R2X and the ΔF508 cystic fibrosis alleles, in nasal epithelial cells. J. Clin. Invest. 93:1502-1507.
13. 13. Chalkley, G., and A. Harris. 1991. Lymphocyte mRNA as a source for detection of mutations and polymorphism in the CF gene. J. Med. Genet. 28:777-780.
14. 14. Sereth, H., T. Shoshani, N. Bashan, and B. Kerem. 1993. Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis. Hum. Genet. 92:289-295.
15. 15. Allan, J. L., M. Robbie, P. D. Phelan, and D. U. Danks. 1981. Familial occurrence of meconium ileus. Eur. J. Pediatr. 135:291-292.
16. 16. Snouwaert, J. N., K. K. Brigman, A. M. Latour, N. N. Malouf, R. C. Boucher, O. Smithies, and B. H. Koller. 1992. An animal model for cystic fibrosis made by gene targeting. Science 257:1083-1088.
17. 17. Barker, P. M., D. G. Bosworth, R. C. Boucher, and J. R. Yankaskas. 1996. Ion and liquid transport by distal lung epithelia from a F508/3849+10 kb human fetus. Pediatr. Pulmonol. S13:234.
18. 18. Caceres, J. F., S. Stamm, D. M. Helfman, and A. R. Krainer. 1994. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265:1706-1709.
19. 19. Zahler, A. M., K. M. Neugebauer, W. S. Lane, and M. B. Roth. 1993. Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 260:219-222.